ART First-line Treatment Durability in Russia

Clinical trial NCT04253119 · COMPLETED

Trial details

NCT number: NCT04253119
Sponsor: MSD Pharmaceuticals LLC
Status: COMPLETED
Study type: OBSERVATIONAL

HIV-1-infection

Start date: 2019-11-26
Primary completion: 2022-06-30
Enrollment: 536

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.